Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuelin Xia

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
ACS Applied Materials & Interfaces|April 4, 2020
ROS-Responsive Nanoparticles Formed from RGD-Epothilone B Conjugate for Targeted Cancer TherapyXuelin Xia, Xiaoyuan Yang, Ping Huang, et al.
Nano-Micro Letters|December 13, 2021
Self-Assembled Nanomicelles of Affibody-Drug Conjugate with Excellent Therapeutic Property to Cure Ovary and Breast CancersXuelin Xia, Xiaoyuan Yang, Wei Huang, et al.
Biomaterials Science|May 3, 2023
Redox-responsive drug-inhibitor conjugate encapsulated in DSPE-PEG<sub>2k</sub> micelles for overcoming multidrug resistance to chemotherapyPenghui Wang, Yuling Wang, Xuelin Xia, et al.
Chemical Communications (Cambridge, England)|January 19, 2017
Integration of multiple active sites on large-pore mesoporous silica for enantioselective tandem reactionsXuelin Xia, Jingjing Meng, Hanxin Wu, et al.
Biomacromolecules|September 5, 2024
Affibody-Functionalized Elastin-like Peptide-Drug Conjugate Nanomicelle for Targeted Ovarian Cancer TherapyQingrong Li, Xiaoyuan Yang, Xuelin Xia, et al.
Molecular Pharmaceutics|September 20, 2021
Improving Targeted Delivery and Antitumor Efficacy with Engineered Tumor Necrosis Factor-Related Apoptosis Ligand-Affibody Fusion ProteinXiaoyuan Yang, Xuelin Xia, Xiao-Xia Xia, et al.
Journal of Nanobiotechnology|August 21, 2024
A novel HER2 targeting nanoagent self-assembled from affibody-epothilone B conjugate for cancer therapyXuelin Xia, Xiaoyuan Yang, Wenhui Gao, et al.
ACS Applied Bio Materials|September 3, 2025
A Nanodrug Self-Assembled from a Redox-Responsive Cabazitaxel-Zosuquidar Conjugate and DSPE-PEG<sub>2k</sub> Reverses Multidrug Resistance in Nonsmall Cell Lung CancerYingchun Liu, Penghui Wang, Wenhui Gao, et al.
Journal of the American Chemical Society|May 30, 2025
Chemically Engineered Affinity Protein Drugs for Covalent Targeted Cancer TherapyXuelin Xia, Wenhui Gao, Xiaoyuan Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 17, 2025
Covalent Affibody-Molecular Glue Drug Conjugate Nanoagent for Proximity-Enabled Reactive TherapeuticsWenhui Gao, Xiaoyuan Yang, Qingrong Li, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
ACS Applied Materials & Interfaces|April 4, 2020
ROS-Responsive Nanoparticles Formed from RGD-Epothilone B Conjugate for Targeted Cancer TherapyXuelin Xia, Xiaoyuan Yang, Ping Huang, et al.
Nano-Micro Letters|December 13, 2021
Self-Assembled Nanomicelles of Affibody-Drug Conjugate with Excellent Therapeutic Property to Cure Ovary and Breast CancersXuelin Xia, Xiaoyuan Yang, Wei Huang, et al.
Biomaterials Science|May 3, 2023
Redox-responsive drug-inhibitor conjugate encapsulated in DSPE-PEG<sub>2k</sub> micelles for overcoming multidrug resistance to chemotherapyPenghui Wang, Yuling Wang, Xuelin Xia, et al.
Chemical Communications (Cambridge, England)|January 19, 2017
Integration of multiple active sites on large-pore mesoporous silica for enantioselective tandem reactionsXuelin Xia, Jingjing Meng, Hanxin Wu, et al.
Biomacromolecules|September 5, 2024
Affibody-Functionalized Elastin-like Peptide-Drug Conjugate Nanomicelle for Targeted Ovarian Cancer TherapyQingrong Li, Xiaoyuan Yang, Xuelin Xia, et al.
Molecular Pharmaceutics|September 20, 2021
Improving Targeted Delivery and Antitumor Efficacy with Engineered Tumor Necrosis Factor-Related Apoptosis Ligand-Affibody Fusion ProteinXiaoyuan Yang, Xuelin Xia, Xiao-Xia Xia, et al.
Journal of Nanobiotechnology|August 21, 2024
A novel HER2 targeting nanoagent self-assembled from affibody-epothilone B conjugate for cancer therapyXuelin Xia, Xiaoyuan Yang, Wenhui Gao, et al.
ACS Applied Bio Materials|September 3, 2025
A Nanodrug Self-Assembled from a Redox-Responsive Cabazitaxel-Zosuquidar Conjugate and DSPE-PEG<sub>2k</sub> Reverses Multidrug Resistance in Nonsmall Cell Lung CancerYingchun Liu, Penghui Wang, Wenhui Gao, et al.
Journal of the American Chemical Society|May 30, 2025
Chemically Engineered Affinity Protein Drugs for Covalent Targeted Cancer TherapyXuelin Xia, Wenhui Gao, Xiaoyuan Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 17, 2025
Covalent Affibody-Molecular Glue Drug Conjugate Nanoagent for Proximity-Enabled Reactive TherapeuticsWenhui Gao, Xiaoyuan Yang, Qingrong Li, et al.
Pageof 2